ISPOR 2026
Sunday, May 17 - Wednesday, May 20
-
EMBEDDED QUALITATIVE INTERVIEWS - GUIDANCE AND PRACTICE BY MAJOR HTA BODIES
Mar 18, 2026, 21:38 PM -
SLEEP AND PSYCHOLOGICAL WELL-BEING IN U.S. AND SOUTH KOREAN ADOLESCENTS
Mar 18, 2026, 21:38 PM -
THE IMPACT OF THE FIRST FAMILY CORONAVIRUS RESPONSE ACT ON HEALTHCARE SERVICE UTILIZATION AMONG MEDICAID BENEFICIARIES WITH SICKLE CELL DISEASE IN WISCONSIN
Mar 18, 2026, 21:38 PM -
TARGET POPULATION SIZE AND LAUNCH PRICE DYNAMICS OF CELL AND GENE THERAPIES (CGTS)
Mar 18, 2026, 21:38 PM -
WHAT'S IN AN ABSTRACT? PICOS REPORTING FREQUENCIES TO INFORM AI-ASSISTED SCREENING
Mar 18, 2026, 21:38 PM -
A MODULAR ONCOLOGY REFERENCE MODEL FOR EARLY ECONOMIC EVALUATION: A CASE STUDY IN EGFR-MUTATED NSCLC
Mar 18, 2026, 21:38 PM -
DEVELOPMENT AND VALIDATION OF A NOMOGRAM TO PREDICT OVERALL SURVIVAL IN NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
CONCOMITANT USE OF DPP4 INHIBITORS AND RAAS INHIBITORS AND RISK OF ANGIOEDEMA: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
THE ICEBERG STUDY: VALIDATING PATIENT RIGHT OF ACCESS DATA COLLECTION AS A NOVEL METHOD FOR LONGITUDINAL RWD GENERATION IN CLINICAL RESEARCH
Mar 18, 2026, 21:38 PM -
HEALTHCARE UTILIZATION AND COSTS ATTRIBUTABLE TO CLINICALLY IMPACTFUL IMMUNE-RELATED ADVERSE EVENTS AMONG OLDER ADULTS WITH ADVANCED NON-SMALL CELL LUNG CANCER TREATED WITH IMMUNE CHECKPOINT INHIBITORS
Mar 18, 2026, 21:38 PM -
FDA APPROVALS OF SPECIALTY DRUGS, 2000-2024
Mar 18, 2026, 21:38 PM -
ACCESS CHALLENGES IDENTIFIED BY WOMEN WITH CARDIOVASCULAR DISEASE: FINDINGS FROM THE SECOND PHASE OF THE PATIENT-LED INSIGHTS AND PATIENT EXPERIENCES WITH CARDIOVASCULAR DISEASE (IPEC2) INITIATIVE
Mar 18, 2026, 21:38 PM -
CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN CISPLATIN ELIGIBLE VERSUS CISPLATIN INELIGIBLE MUSCLE INVASIVE BLADDER CANCER PATIENTS WITH INTENT FOR RESECTION: A MULTICOUNTRY RETROSPECTIVE CHART REVIEW IN EUROPE
Mar 18, 2026, 21:38 PM -
MEAN OVERALL SURVIVAL FROM THE PHASE 3 MIRASOL TRIAL OF MIRVETUXIMAB SORAVTANSINE VS INVESTIGATOR’S CHOICE OF CHEMOTHERAPY IN WOMEN WITH FR?-HIGH PLATINUM-RESISTANT OVARIAN CANCER (GOG 3045/ENGOT-OV55; NCT04209855)
Mar 18, 2026, 21:38 PM -
IMPACT OF COVID-19 PANDEMIC ON HEALTHCARE UTILIZATION IN THE US AS OBSERVED IN FEDERATED ELECTRONIC HEALTH RECORDS: 2016 TO 2022
Mar 18, 2026, 21:38 PM -
CHARACTERIZING THE PATIENTS WITH FIBROMYALGIA: A US REAL-WORLD CLAIMS ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD SURVIVAL AND PREDICTORS OF MORTALITY IN HEMATOLOGIC MALIGNANCIES DURING AN ERA OF THERAPEUTIC ADVANCEMENT AND HEALTHCARE DISRUPTION: A POPULATION-BASED SEER STUDY
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN PINEAL NEOPLASM AND ALZHEIMER’S DISEASE PROGRESSION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT: A POPULATION-BASED COHORT STUDY
Mar 18, 2026, 21:38 PM -
ASSESSING DRIVERS OF PAYER CONTROL IN RARE DISEASE
Mar 18, 2026, 21:38 PM -
VALIDATION OF AN AI-ASSISTED EVIDENCE SYNTHESIS IN HEOR
Mar 18, 2026, 21:38 PM